+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Implantable Insulin Pump Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

  • Report

  • 100 Pages
  • September 2021
  • Region: Global
  • Infinium Global Research
  • ID: 5455850
The report on the global implantable insulin pump market provides qualitative and quantitative analysis for the period from 2021 to 2027. The report predicts the global implantable insulin pump market to grow with a CAGR of 9.5% over the forecast period from 2021-2027. The study on implantable insulin pump market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2021 to 2027.

The report on implantable insulin pump market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global implantable insulin pump market over the period of 2021 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global implantable insulin pump market over the period of 2021 to 2027. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings


1) Drivers

  • Increasing incidence rates of diabetes worldwide
  • Rise in base of geriatric population

2) Restraints

  • Lengthy process of governmental approvals and compliance with rules and regulations

3) Opportunities

  • High growth potential in emerging markets

Research Methodology


A) Primary Research


Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

A) Primary Research


Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global implantable insulin pump market is segmented on the basis of type, and end user.

The Global Implantable Insulin Pump Market by Type

  • Closed-loop Insulin Pump
  • Open-loop Insulin Pump

The Global Implantable Insulin Pump Market by End User

  • Hospitals
  • Home Care

Company Profiles


The companies covered in the report include
  • CVS Health (Aetna Inc.)
  • Diabeloop
  • Apex Medical Diamesco Co., Ltd
  • F. Hoffmann La Roche Ltd
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic Plc
  • Tandem Diabetes Care
  • SOOIL Developments Co. Ltd.

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the implantable insulin pump market.
2. Complete coverage of all the segments in the implantable insulin pump market to analyze the trends, developments in the Scope name market and forecast of market size up to 2027.
3. Comprehensive analysis of the companies operating in the global implantable insulin pump market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Implantable Insulin Pump Market Highlights
2.2. Implantable Insulin Pump Market Projection
2.3. Implantable Insulin Pump Market Country Highlights
3. Global Implantable Insulin Pump Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Implantable Insulin Pump Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.5.1. Growth Matrix Analysis by Type
3.5.2. Growth Matrix Analysis by End User
3.5.3. Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Implantable Insulin Pump Market
4. Implantable Insulin Pump Market Macro Indicator Analysis
5. Global Implantable Insulin Pump Market by Type
5.1. Closed-loop Insulin Pump
5.2. Open-loop Insulin Pump
6. Global Implantable Insulin Pump Market by End User
6.1. Hospitals
6.2. Home Care
7. Global Implantable Insulin Pump Market by Region 2021-2027
7.1. North America
7.1.1. North America Implantable Insulin Pump Market by Type
7.1.2. North America Implantable Insulin Pump Market by End User
7.1.3. North America Implantable Insulin Pump Market by Country
7.2. Europe
7.2.1. Europe Implantable Insulin Pump Market by Type
7.2.2. Europe Implantable Insulin Pump Market by End User
7.2.3. Europe Implantable Insulin Pump Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Implantable Insulin Pump Market by Type
7.3.2. Asia-Pacific Implantable Insulin Pump Market by End User
7.3.3. Asia-Pacific Implantable Insulin Pump Market by Country
7.4. RoW
7.4.1. RoW Implantable Insulin Pump Market by Type
7.4.2. RoW Implantable Insulin Pump Market by End User
7.4.3. RoW Implantable Insulin Pump Market by Sub-region
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Implantable Insulin Pump Market
8.2. Companies Profiled
8.2.1. CVS Health (Aetna Inc.)
8.2.2. Diabeloop
8.2.3. Apex Medical Diamesco Co., Ltd
8.2.4. F. Hoffmann La Roche Ltd
8.2.5. Insulet Corporation
8.2.6. Johnson & Johnson
8.2.7. Medtronic Plc
8.2.8. Tandem Diabetes Care
8.2.9. SOOIL Developments Co. Ltd.

Companies Mentioned

  • CVS Health (Aetna Inc.)
  • Diabeloop
  • Apex Medical Diamesco Co., Ltd
  • F. Hoffmann La Roche Ltd
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic Plc
  • Tandem Diabetes Care
  • SOOIL Developments Co. Ltd.